AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.65
-1.35 (-8.44%)
At close: Feb 6, 2026, 4:00 PM EST
14.11
-0.54 (-3.69%)
After-hours: Feb 6, 2026, 7:59 PM EST
AgomAb Therapeutics NV Employees
AgomAb Therapeutics NV had 58 employees as of December 31, 2024. The number of employees increased by 24 or 70.00% compared to the previous year.
Employees
58
Change
24
Growth
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,466,924
Market Cap
713.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 58 | 24 | 70.00% |
| Dec 31, 2023 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 837 |
| Gyre Therapeutics | 579 |
| KalVista Pharmaceuticals | 270 |
| Kura Oncology | 192 |
| Cullinan Therapeutics | 111 |
| Nektar Therapeutics | 61 |
| Arbutus Biopharma | 44 |
| SELLAS Life Sciences Group | 15 |
AGMB News
- 10 hours ago - U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years - Seeking Alpha
- 19 hours ago - Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut - Reuters
- 1 day ago - Agomab Announces Pricing of Initial Public Offering - GlobeNewsWire
- 7 days ago - U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January - Seeking Alpha
- 8 days ago - AgomAb Therapeutics NV Readies US IPO On Early Promising Results - Seeking Alpha
- 21 days ago - Agomab Therapeutics files for US IPO - Reuters
- 21 days ago - AgomAb Therapeutics IPO Registration Document (F-1) - SEC